Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Sale May Be Sequenom's Only Option
TheStreet.com
Tuesday, September 29, 2009 - 8:57am
tags:
Sequenom
Cervarix a Step Closer to FDA Approval
Yahoo/Zacks.com
Tuesday, September 29, 2009 - 8:55am
tags:
Cervarix, FDA, GSK, cervical cancer, HPV, Merck, Gardasil
Sanofi-Aventis: Zimulti US Class Action Suit Dismissed
WSJ Online
Tuesday, September 29, 2009 - 8:50am
tags:
lawsuits, Sanofi, Zimulti
Which Pfizer / Wyeth Sites Will Close?
In the Pipeline
Tuesday, September 29, 2009 - 8:47am
tags:
Pfizer, Wyeth, M&A, reorganization
FDA doubts Repros' Proellex can be safe
Marketwatch
Tuesday, September 29, 2009 - 8:46am
tags:
Repros Therapeutics, Proellex, FDA
Merck diabetes drug cut blood sugar over two years
Marketwatch
Tuesday, September 29, 2009 - 8:45am
tags:
Merck, diabetes, Januvia
Sanofi-Aventis to launch insulin research program
Marketwatch
Tuesday, September 29, 2009 - 8:45am
tags:
insulin, diabetes, Sanofi
Abbott's Vascular Segment Should Keep Pumping Growth in China
Seeking Alpha
Tuesday, September 29, 2009 - 8:44am
tags:
Abbott Laboratories, China, stents, Xience
Questcor Pharmaceuticals: Risky, But Cheap
Seeking Alpha
Monday, September 28, 2009 - 5:22pm
tags:
Questcor Pharmaceuticals
Sequenom Study Found Unreliable
TheStreet.com
Monday, September 28, 2009 - 5:21pm
tags:
Sequenom, drug trials
J&J's Knockout Drug
Motley Fool
Monday, September 28, 2009 - 3:53pm
tags:
JNJ, Stelara, Amgen, Wyeth, psoriasis, Humira, Embrel
Merck shares jump on flu-shot distribution deal
Marketwatch
Monday, September 28, 2009 - 2:57pm
tags:
Merck, vaccines, CSL, Afluria, Flu
Launch of Novartis Drug Awaited
Yahoo/Zacks.com
Monday, September 28, 2009 - 2:10pm
tags:
Novartis, Valturna, antihypertensives, Tekturna, Diovan
Cash Deal Helps Abbott
Barron's
Monday, September 28, 2009 - 2:10pm
tags:
Abbott Laboratories, Solvay, M&A
Crucell Finds Partner in J&J After Wyeth Walks Away
Bloomberg
Monday, September 28, 2009 - 12:15pm
tags:
Crucell, M&A, vaccines, JNJ, Wyeth
Benlysta Should be a Blockbuster
Yahoo/Zacks.com
Monday, September 28, 2009 - 12:09pm
tags:
Benlysta, GSK, lupus, Human Genome Sciences
Financing Activity for Biotech Deals Heats Up
Seeking Alpha
Monday, September 28, 2009 - 11:24am
tags:
Abbott Laboratories, AstraZeneca, Biogen Idec, Nektar, Solvay, Qiagen, Warner Chilcott, Zogenix, Inhibitex
10 Health-Care Stocks To Consider Buying Now
iStockAnalyst
Monday, September 28, 2009 - 11:20am
tags:
Zimmer, JNJ, Covidien, Becton Dickinson, Abbott Laboratories, Merck, Medtronic, Novartis, Bristol-Myers Squibb, Genzyme
AstraZeneca caught up in bid talk as US mega-deals lift Dow and FTSE 100
Guardian, UK
Monday, September 28, 2009 - 11:18am
tags:
AstraZeneca, M&A
Roche U.S. cancer drug trial enrollment suspended
Reuters
Monday, September 28, 2009 - 11:14am
tags:
Roche, Avastin, drug trials, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.